The American Psychiatric Publishing textbook of psychopharmacology
The DOI matches its Crossref record.
Abstract
Part I: Principles of Psychopharmacology. Neurotransmitters, receptors, signal transduction, and second messengers in psychiatric disorders. Basic principles of molecular biology and genomics. Chemical neuroanatomy of the primate brain. Electrophysiology. Animal models. Psychoneuroendocrinology. Principles of pharmacokinetics and pharmacodynamics. Brain-immune system interactions: relevance to the pathophysiology and treatment of neuropsychiatric disorders. Brain imaging in psychopharmacology. Statistics and clinical trial design in psychopharmacology. Pharmacoeconomics. Part II: Classes of Psychiatric Treatments: animal and human pharmacology. Antidepressants and Anxiolytics. Tricyclic and tetracyclic drugs. Fluoxetine. Sertraline. Paroxetine. Fluvoxamine. Citalopram and s-citalopram. Monoamine oxidase inhibitors. Trazodone and nefazodone. Bupropion. Mirtazapine. Venlafaxine. Duloxetine and milnacipran. Benzodiazepines. Buspirone and gepirone. Investigational treatments for mood and anxiety disorders: CRH receptor antagonists, NK-1 receptor antagonists, and glucocorticoid receptor antagonists. Antipsychotics. Classic antipsychotic medications. Clozapine. Olanzapine. Quetiapine. Aripiprazole. Risperidone. Ziprasidone. Drugs to treat extrapyramidal side effects. Drugs for Treatment of Bipolar Disorder. Lithium. Valproate. Carbamazepine and oxcarbazepine. Gabapentin. Lamotrigine. Topiramate. Other Agents. Cognitive enhancers. Sedative-hypnotics. Psychostimulants in psychiatry: amphetamine, methylphenidate, and modafinil. Electroconvulsive therapy. Part III: Clinical Psychobiology and Psychiatric Syndromes. Biology of mood disorders. Neurobiology of schizophrenia. Neurobiology of anxiety disorders. Biology of Alzheimer's disease. Neurobiology of substance abuse disorders. Biology of eating disorders. Biology of personality disorders. Part IV: Psychopharmacological Treatment. Treatment of depression. Treatment of bipolar disorder. Treatment of schizophrenia. Treatment of anxiety disorders. Management of noncognitive symptoms of dementia: behavioral and psychological symptoms of dementia. Treatment of childhood and adolescent disorders. Treatment of substance-related disorders. Treatment of eating disorders. Treatment of agitation and aggression in the elderly. Treatment of personality disorders. Psychiatric emergencies. Treatment during late life. Psychopharmacology during pregnancy and lactation. Treatment of insomnia. Index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review
Potvin, S., Stip, E., Sepehry, A. A., Gendron, A., Bah, R., & Kouassi, E. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.09.024 · Cited by 858
Approaches for enhancing oral bioavailability of peptides and proteins
Renukuntla, J., Vadlapudi, A. D., Patel, A., Boddu, S. H. S., & Mitra, A. K. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.02.030 · Cited by 681
Current Concepts and Treatments of Schizophrenia
Stępnicki, P., Kondej, M., & Kaczor, A. A. (2018) · Molecules · doi:10.3390/molecules23082087 · Cited by 556
Depression in cancer patients: Pathogenesis, implications and treatment (Review)
SMITH, H. R. (2015) · Oncology Letters · doi:10.3892/ol.2015.2944 · Cited by 478
5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants
Richardson-Jones, J. W., Craige, C. P., Guiard, B. P., Stephen, A., Metzger, K. L., Kung, H. F., Gardier, A. M., Dranovsky, A., David, D. J., Beck, S. G., et al. (2010) · Neuron · doi:10.1016/j.neuron.2009.12.003 · Cited by 450
Charney, D. S., & Manji, H. K. (2004) · Science's STKE · doi:10.1126/stke.2252004re5 · Cited by 429
Current state and challenges in developing oral vaccines
Vela Ramirez, J. E., Sharpe, L. A., & Peppas, N. A. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.04.008 · Cited by 412
Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery
Atkin, T., Comai, S., & Gobbi, G. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014381 · Cited by 391
de Leon, J., Susce, M. T., Pan, R.-M., Fairchild, M., Koch, W. H., & Wedlund, P. J. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0103 · Cited by 319
A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia
Huey, E. D., Putnam, K. T., & Grafman, J. (2006) · Neurology · doi:10.1212/01.wnl.0000191304.55196.4d · Cited by 299
The Effects of Magnesium Supplementation on Subjective Anxiety and Stress—A Systematic Review
Boyle, N., Lawton, C., & Dye, L. (2017) · Nutrients · doi:10.3390/nu9050429 · Cited by 162
An update of safety of clinically used atypical antipsychotics
Orsolini, L., Tomasetti, C., Valchera, A., Vecchiotti, R., Matarazzo, I., Vellante, F., Iasevoli, F., Buonaguro, E. F., Fornaro, M., Fiengo, A. L. C., et al. (2016) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2016.1201475 · Cited by 135
Campayo, A., Gómez-Biel, C. H., & Lobo, A. (2011) · Current Psychiatry Reports · doi:10.1007/s11920-010-0165-z · Cited by 116
An update on the role of glutamate in the pathophysiology of depression
Mitchell, N. D., & Baker, G. B. (2010) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2009.01529.x · Cited by 91
Pharmacological management of binge eating disorder: current and emerging treatment options
McElroy, S., Guerdjikova, A. I., Mori, N., & O’Melia, A. (2012) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s25574 · Cited by 74
Grob, C. S., Bossis, A. P., & Griffiths, R. R. (2013) · Psychological Aspects of Cancer · doi:10.1007/978-1-4614-4866-2_17 · Cited by 53
Then, C.-K., Chi, N.-F., Chung, K.-H., Kuo, L., Liu, K.-H., Hu, C.-J., Shen, S.-C., & Lin, Y.-K. (2017) · PLOS ONE · doi:10.1371/journal.pone.0175187 · Cited by 35
Brain-derived neurotrophic factor as a suicide factor in mental disorders
Grah, M., Mihanovic, M., Ruljancic, N., Restek-Petrovic, B., Molnar, S., & Jelavic, S. (2014) · Acta Neuropsychiatrica · doi:10.1017/neu.2014.27 · Cited by 29
Ready, R. E., Baran, B., Chaudhry, M., Schatz, K., Gordon, J., & Spencer, R. M. C. (2011) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/1533317511421921 · Cited by 21
Metadata
- Venue
- Choice Reviews Online
- Publisher
- American Library Association
- Published
- 2010-04-01
- Volume
- 47
- Issue
- 08
- Pages
- 47-4164-47-4164
- ISSN
- 0009-4978 (ISSN-L)
- 1523-8253
- OpenAlex
- W1579215575
- Cited by
- 233
- References
- 0
- Type
- book review
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.